Andrew Boulle
Andrew Boulle
School of Public Health and Family Medicine, University of Cape Town
Verified email at uct.ac.za
TitleCited byYear
Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.
P Braitstein, MW Brinkhof, F Dabis, M Schechter, A Boulle, P Miotti, ...
Lancet 367 (9513), 817, 2006
11562006
Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa
D Coetzee, K Hildebrand, A Boulle, G Maartens, F Louis, V Labatala, ...
Aids 18 (6), 887-895, 2004
7132004
Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries
MWG Brinkhof, F Dabis, L Myer, DR Bangsberg, A Boulle, D Nash, ...
Bulletin of the World Health Organization 86 (7), 559-567, 2008
3732008
Life Expectancies of South African Adults Starting Antiretroviral Treatment: Collaborative Analysis of Cohort Studies
LF Johnson, J Mossong, RE Dorrington, M Schomaker, CJ Hoffmann, ...
PLoS Medicine 10 (4), e1001418, 2013
3122013
Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa
A Boulle, G Van Cutsem, K Hilderbrand, C Cragg, M Abrahams, S Mathee, ...
Aids 24 (4), 563-572, 2010
2752010
Task shifting of antiretroviral treatment from doctors to primary-care nurses in South Africa (STRETCH): a pragmatic, parallel, cluster-randomised trial
L Fairall, MO Bachmann, C Lombard, V Timmerman, K Uebel, ...
The Lancet 380 (9845), 889-898, 2012
2442012
Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002–2007
M Cornell, A Grimsrud, L Fairall, MP Fox, G van Cutsem, J Giddy, R Wood, ...
AIDS (London, England) 24 (14), 2263, 2010
2412010
Outcomes of nevirapine-and efavirenz-based antiretroviral therapy when coadministered with rifampicin-based antitubercular therapy
A Boulle, G Van Cutsem, K Cohen, K Hilderbrand, S Mathee, M Abrahams, ...
Jama 300 (5), 530-539, 2008
2392008
Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes
M May, A Boulle, S Phiri, E Messou, L Myer, R Wood, O Keiser, ...
The Lancet 376 (9739), 449-457, 2010
2172010
Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality
MWG Brinkhof, A Boulle, R Weigel, E Messou, C Mathers, C Orrell, ...
PLoS medicine 6 (4), e1000066, 2009
2042009
Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaboration
P Braitstein, A Boulle, D Nash, MWG Brinkhof, F Dabis, C Laurent, ...
Journal of Women's Health 17 (1), 47-55, 2008
2012008
Effectiveness of antiretroviral treatment in a South African program: a cohort study
LR Fairall, MO Bachmann, G Louwagie, C van Vuuren, P Chikobvu, ...
Archives of Internal Medicine 168 (1), 86, 2008
2002008
Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America
O Keiser, K Anastos, M Schechter, E Balestre, L Myer, A Boulle, ...
Trop Med Int Health 13 (7), 870-879, 2008
1982008
Promoting adherence to antiretroviral therapy: the experience from a primary care setting in Khayelitsha, South Africa
D Coetzee, A Boulle, K Hildebrand, V Asselman, G Van Cutsem, ...
Aids 18, S27-S31, 2004
1982004
Cohort Profile: The international epidemiological databases to evaluate AIDS (IeDEA) in sub-Saharan Africa
M Egger, DK Ekouevi, C Williams, RE Lyamuya, H Mukumbi, P Braitstein, ...
International journal of epidemiology 41 (5), 1256-1264, 2012
1762012
Electronic medical record systems, data quality and loss to follow-up: survey of antiretroviral therapy programmes in resource-limited settings
M Forster, C Bailey, MWG Brinkhof, C Graber, A Boulle, M Spohr, ...
Bulletin of the World Health Organization 86 (12), 939-947, 2008
1762008
Antiretroviral therapy and early mortality in South Africa
A Boulle, P Bock, M Osler, K Cohen, L Channing, K Hilderbrand, ...
Bulletin of the World Health Organization 86 (9), 678-687, 2008
1682008
Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial
MX Rangaka, RJ Wilkinson, A Boulle, JR Glynn, K Fielding, G van Cutsem, ...
The Lancet 384 (9944), 682-690, 2014
1642014
Gender Differences in Survival among Adult Patients Starting Antiretroviral Therapy in South Africa: A Multicentre Cohort Study
M Cornell, M Schomaker, DB Garone, J Giddy, CJ Hoffmann, R Lessells, ...
PLoS Medicine 9 (9), e1001304, 2012
1642012
Public-health and individual approaches to antiretroviral therapy: township South Africa and Switzerland compared
O Keiser, C Orrell, M Egger, R Wood, MWG Brinkhof, H Furrer, ...
PLoS medicine 5 (7), e148, 2008
1512008
The system can't perform the operation now. Try again later.
Articles 1–20